Cytogenetic and loss of heterozygosity studies in ependymomas, pilocytic astrocytomas, and oligodendrogliomas.
Cytogenetic and/or loss of heterozygosity studies were performed on 13 ependymomas, 11 pilocytic astrocytomas, and 18 oligodendrogliomas. Loss of chromosome 22 was the most frequent genetic abnormality among the ependymomas. We found no consistent genetic abnormality in pilocytic astrocytomas. The most common genetic abnormality in oligodendrogliomas was loss of a portion of chromosome 19. Each informative oligodendroglioma had loss of alleles mapped to the long arm (q) of chromosome 19. One oligodendroglioma had an apparent homozygous deletion of the D19S8 locus. Our results, when combined with those in the literature, indicate that chromosomes 9, 11, and 22 may harbor genes important for the pathogenesis of ependymomas and that 19q probably harbors a gene important for the pathogenesis of oligodendrogliomas.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000483:Alleles; D001254:Astrocytoma / Q000097:blood / Q000235:genetics* / Q000473:pathology; D001932:Brain Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D002888:Chromosomes, Human, Pair 19 / Q000648:ultrastructure; D004273:DNA, Neoplasm / Q000097:blood / Q000235:genetics; D004806:Ependymoma / Q000097:blood / Q000235:genetics* / Q000473:pathology; D005260:Female; D005819:Genetic Markers; D006801:Humans; D007223:Infant; D007621:Karyotyping; D008297:Male; D008875:Middle Aged; D009837:Oligodendroglioma / Q000097:blood / Q000235:genetics* / Q000473:pathology; D017384:Sequence Deletion
D004273:DNA, Neoplasm; D005819:Genetic Markers